The global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the increasing prevalence of chronic nervous disorders. The rising demand for minimally invasive surgeries due to the growing preference among patients and doctors for faster recovery and shorter hospital stays is expected to drive the growth of neurostimulation devices. The increasing prevalence of neurological disorders, such as epilepsy, Dystonia, Parkinson's diseases, is most likely to drive the demand for neurostimulation devices. Technological advancement in the healthcare infrastructure of several countries through the implementation of intelligent technologies is expected to boost the demand for the devices. Implementation of advanced technologies such as Artificial intelligence and machine learning is helping in the development of smart neuromodulation, which is most likely to benefit the patients suffering from brain damage.

The research takes a closer look at prominent factors driving the growth rate of the prominent product categories across major geography. Furthermore, the study covers a lot of the sales, gross margin, consumption capacity, spending power and customer preference across various countries. The report offers clear indications how the Neurostimulation Devices market is expected to witness numerous exciting opportunities in the years to come. Critical aspects including the growing requirement, demand and supply status, customer preference, distribution channels and others are presented through resources such as charts, tables, and infographics.

Read more@ https://www.emergenresearch.com/industry-report/neurostimulation-de...

Key Highlights From The Report

In 2019, Medtronic launched the Intellis platform for the management of certain types of chronic intractable pain.

The platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow. It can track patients 24/7 and help in monitoring chronic pain.

The spinal cord stimulator segment held the largest market share of 46.2% in 2019. The rising need for treating spinal injuries and neuropathic pain is most likely to increase the demand for the Spinal Cord Stimulators across the globe.

Pain management is forecasted to grow with the fastest CAGR of 14.0%. The increasing incidence of chronic and acute pain disorders among patients suffering from neurological disorders is expected to increase the usage of neurostimulation devices for pain management.

The Asia Pacific region is expected to be the fastest-growing region over the forecast period. The economic development and increasing Healthcare Budgetary

Allocation in developing countries is expected to drive the growth of neurostimulation devices in the region.

Key participants include BOSTON SCIENTIFIC CORPORATION, ST. JUDE MEDICAL, MEDTRONIC, NEURONETICS, INC., Codman & Shurtleff, Inc., NEVRO CORPORATION, INTRAPACE, Abbott Laboratories, LivaNova PLC, and Bayer AG, among others.

Request For Free Sample@ https://www.emergenresearch.com/request-sample/349

Product Outlook (Revenue, USD Billion; 2017-2027)
Sacral Nerve stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulators
Deep Brain Stimulators

Application Outlook (Revenue, USD Billion; 2017-2027)
Epilepsy
Depression
Dystonia
Gastroparesis
Pain management
Urinary and Fecal Incontinence
Essential Tremor
Parkinson’s Disease
Others

Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA

Table of Content

Chapter 1. Methodology & Sources

1.1. Neurostimulation Devices Market Definition
1.2. Neurostimulation Devices Market Research Scope
1.3. Neurostimulation Devices Market Methodology
1.4. Neurostimulation Devices Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Neurostimulation Devices Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Neurostimulation Devices MarketSegmentation & Impact Analysis

Continued…